KELSEA LEROSE: Open Payments
NPI 1124629936 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 15 payments from 8 companies in 2025. Trend: 2023 $232 · 2024 $357 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $57 |
| Dexcom, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $39 |
| Exeltis, USA Inc. | 2 | $29 |
| Boston Scientific Corporation | 1 | $29 |
| Exact Sciences Corporation | 2 | $28 |
| Biogen, Inc. | 1 | $24 |
| MILLICENT US INC | 1 | $17 |
Products named: Mirena, Dexcom G6 Transmitter, Veozah, SLYND, Axonics, Cologuard Collection Kit, ZURZUVAE, FEMLYV.
Industry payments across IN — which companies pay providers there.
